Th. Ochilohmann et al., RADIOSENSITIVITY OF BLOOD-LYMPHOCYTES FROM BASOCELLULAR CARCINOMA PATIENTS, AS DETECTED BY THE MICRONUCLEUS ASSAY, Mutation research, 357(1-2), 1996, pp. 97-106
Cytogenetic techniques, the micronucleus (MN) assay, in particular, ha
ve been widely used in population monitoring, biological dosimetry and
early detection of groups susceptible to cancer. Individuals respond
differently to several environmental agents. The efficiency of the cel
lular repair mechanisms would be responsible, at least to some extent,
for individual differences in sensitivity to neoplasia. In order to d
etermine the sensitivity of cancer patients to ionizing radiation, blo
od cultures from untreated individuals with basocellular carcinoma, yo
ung healthy subjects and older healthy subjects, were irradiated in vi
tro with Co-60 at doses ranging from 0 to 500 cGy and submitted to the
cyto-B micronucleus assay; the frequency of cells and distribution of
MN and dose-response relationships were analyzed. Results showed that
cancer patients had a lower frequency of cells with spontaneous MN th
an older healthy subjects. The frequency of micronucleated cells was n
ot different in patients and healthy subjects, but not the distributio
n of MN per radiation dose: for the carcinoma group, while the proport
ion of cells with one MN decreases drastically, the proportion of the
cells with two or more MN increases with the same intensity. Our resul
ts show that the proportion of damaged cells is similar in patients wi
th basocellular carcinoma and healthy subjects, but the magnitude of r
adiation-induced lesion is greater in the cancer patients.